Dovramilast

Overview

Dovramilast (CC-11050) is an orally active phosphodiesterase 4 ( PDE4 ) inhibitor and can reduce the inflammatory response and improves Isoniazid ( HY-B0329 )-mediated bacillary clearance from the lungs. Dovramilast, as an adjunct, is used for the research of tuberculosis (TB).

Application

Products | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Colorectal Cancer | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Depression | Products > Disease Areas > Mycobacterium Tuberculosis Infection | Products > Disease Areas > Alzheimer's Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Bacterial Infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Infection | Products > Signaling Pathways > Phosphodiesterase (PDE)

Product Information

• Catalog No.: HY-147263
• CAS No.: 340019-69-4
• Molecular Formula: C24H28N2O6S
• Molecular Weight: 472.55
• Purity: 99.66%
• Storage: 4°C, sealed storage, away from moisture and light * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
• Availability: In-stock

Source

Original product source